Neuvosyn Laboratories, LLC

Quick facts

Marketed products

• North Star · Diabetes
  North Star is a small molecule that acts as a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2).

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Neuvosyn Laboratories, LLC portfolio CI brief
• Neuvosyn Laboratories, LLC pipeline updates RSS